Cargando…
The anti-B7-H3 blocking antibody MJ18 does not recognize B7-H3 in murine tumor models
The immune checkpoint molecule B7-H3 is regarded as one of the most promising therapeutic targets for the treatment of human cancers. B7-H3 is highly expressed in many cancers and its expression has been associated to impaired antitumor immunity and poor patient prognosis. In immunocompetent mouse t...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cold Spring Harbor Laboratory
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680724/ https://www.ncbi.nlm.nih.gov/pubmed/38014341 http://dx.doi.org/10.1101/2023.11.15.567261 |